Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab + FOLFOXIRI for KRAS/NRAS Wild-Type Colorectal Cancer with Liver Metastases
NCT02063529Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2014
- Primary completion
- Dec 2019
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cetuximab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Feb 2014; status: completed.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02063529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02063529.